BACKGROUND To retrospectively evaluate the outcome of patients with inoperable non-small-cell lung cancer treated with primary external beam radiotherapy combined with high-dose-rate endobronchial brachytherapy boost. PATIENTS AND METHODS Between 1988 and 2005, 35 patients with non-small-cell lung cancer (stage I-III) ineligible for surgical resection and/or chemotherapy, were primarily treat...

The COVID-19 pandemic has precipitated large declines in childhood vaccination coverage and, consequently, substantial increases the number of zero-dose children. To effectively respond to these declines, it is necessary direct resources for recovery. We mapped active external financing immunisation and primary healthcare 20 countries with highest numbers children promote transparency donor coo...

Introduction: Human beings are naturally exposed to ionizing radiation in any environment. There are two main contributors to radiation exposures from natural sources: cosmic rays, Cosmo genic radionuclides, and radioactive nuclides that originated in the earth's crust. According to the latest data provided by the United Nations Scientific Committee on the Effects of Atomic Rad...

UNLABELLED Renal toxicity associated with small-molecule radionuclide therapy has been shown to be dose-limiting for many clinical studies. Strategies for maximizing dose to the target tissues while sparing normal critical organs based on absorbed dose and biologic response parameters are commonly used in external-beam therapy. However, radiopharmaceuticals passing though the kidneys result in ...